19.05.2014 Views

PowerPoint Presentation (PDF) - Perfusion.com

PowerPoint Presentation (PDF) - Perfusion.com

PowerPoint Presentation (PDF) - Perfusion.com

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Case Report<br />

10/08/2009<br />

Case Reports in the Sun<br />

Tampa, Florida<br />

LVAD EXPLANT/OHTx<br />

Michael Varsami<br />

Sh School of Cardiovascular <strong>Perfusion</strong><br />

NSUH/LIU<br />

Class 2010<br />

Director: R. Chan, CCP


• Date: 03/31/2009<br />

• Procedure: LVAD Explant/OHTx<br />

• Heart transported on TransMedics OCS<br />

• Rotation: New York Presbyterian‐Columbia<br />

• Pt’s Age: 24 y/o<br />

• Gender: Male<br />

• Case # 23‐2<br />

• <strong>Perfusion</strong>ists: sts: M.Brewer,CCP e / N. Edson,CCP,<br />

,<br />

C, Farrell, CCP<br />

• <strong>Perfusion</strong> Student: M. Varsami


Heart Failure<br />

• 5 million people<br />

• Class III or IV (New York Heart)<br />

• 50,000 000 potential ti therapy pool<br />

• ~2000 receive Tx<br />

• 48,000 dependant on the reimbursement<br />

of new devices<br />

• Dependent on <strong>Perfusion</strong> and H/L machines


Patient’s Information<br />

• History of present illness:<br />

• 24 y/o male,<br />

• Hx of CHF (EF 15%) from viral DCM on 11/07 (home<br />

on Milrinone)<br />

• S/p PPM/AICD 12/07<br />

• LVAD (HEARTMATE I) placement on 2/1/2009<br />

• Admitted on 3/6/09 with device malfunction (device<br />

was checked)<br />

• Status 1A<br />

• Participant in the Transmedics study & the heart was<br />

transported on the transmedics device.


TransMedics edcs OCS<br />

(Organ Care System)<br />

1 st case @ Columbia Un. Hospital<br />

Organ care system<br />

<strong>Perfusion</strong> module<br />

Priming solution


TransMedics OCS<br />

(Organ Care System)<br />

‣ NOT FDA approved. Still on trials.<br />

‣ Recipient must consent for harvest with TransMedics<br />

OCS<br />

‣ Maintains organ at a near physiologic functioning state<br />

‣ Increasing organs availability<br />

‣ Tremendous reduction of cold ischemic time<br />

‣ Better post operation out<strong>com</strong>es<br />

‣ Easily transportable. Transportation time up to 6‐8 hrs


OCS<br />

• Portable platform<br />

insures the<br />

appropriate<br />

environment for the<br />

organ. Optimizes<br />

perfusion of warm,<br />

oxygenated nutrient<br />

rich blood.


TransMedics OCS<br />

Monitoring<br />

Aortic Pressure<br />

HR<br />

AF (Aortic Flow)<br />

CF (Coronary Flow)<br />

Spo2<br />

Oxygenator/<br />

Blood pump<br />

Hct<br />

Blood Temp.


TransMedics/ <strong>Perfusion</strong> Module<br />

LA/Ao & cardioplegia access points<br />

Flow control<br />

Resting/working mode<br />

<strong>Perfusion</strong> module<br />

Defibrillation pads<br />

Sampling mannifold<br />

PA outlet


TransMedics/ <strong>Perfusion</strong> Module<br />

Visual, functional & metabolic assessments of the organ


Priming Solution<br />

500 mL<br />

Mannitol 12.5g<br />

NaCl 4.8g<br />

KCl 0.185g<br />

Magnesium Sulfate 0.185g<br />

Sodium Glycerophosphate 0.90g<br />

Water for injection 500mL<br />

pH 7.3‐7.6<br />

7.6<br />

Added Medications:<br />

Multivitamin (1 Unit)<br />

HCO3 (20 meq)<br />

Solumedrol (250 mg)


Priming Solution<br />

1. Transmedics Maintenance Infusion (TMI)<br />

Volume: 500 mL<br />

Initial Rate: 10 mL/hr<br />

Adenosine 750 mg<br />

Calcium Chloride Dihydrate 2400 mg<br />

Magnesium Sulfate Heptahydrate 400 mg<br />

Potassium Chloride 20 mg<br />

NCl750<br />

NaCl mg<br />

Amino Acids:<br />

Glycine 350 mg<br />

L‐alanine 174 mg<br />

L‐arginine 700 mg<br />

Aspartic Acid 245 mg<br />

L‐Glutamic Acid 258 mg<br />

L‐Histidine 225 mg<br />

L‐Isoleucine 115.5 mg<br />

L‐Leucine Leucine 343 mg<br />

L‐Methionine 59 mg<br />

L‐Phenylalanine 52 mg<br />

L‐Proline 126 mg<br />

L‐Serine 93 mg<br />

L‐Threonine 92 mg<br />

L‐Valine 171.5 mg<br />

Lysine Acetate 225 mg<br />

2. Epinephrine Drip<br />

Volume 500 mL<br />

Initial Rate: 5 mL/hr<br />

0.25 mg Epinephrine in 500 mL of D5W<br />

30 Units of Insulin


TransMedics OCS/schematic diagram<br />

LA port<br />

Cardioplegia port<br />

Loading mode<br />

Pump<br />

Working mode<br />

PA cannula<br />

Aorta<br />

Reservoir<br />

Oxygenator/HE<br />

(QUADROX D)<br />

PA cannula outlet


TransMedics OCS<br />

Two modes:<br />

Working mode<br />

Resting mode<br />

‣ Unloaded- Resting mode (Retrograde<br />

fashion)<br />

PA → OCS → Ao → CA → CS → RA → PA<br />

‣Loaded- Working mode (Antegrade fashion)<br />

PA → OCS → LA → LV → Ao → CA → CS → RA → PA


Equipments<br />

• Synthesis Hard Shell Venous Reservoir<br />

(open)<br />

‐ Max cardiotomy flow rate 4LPM<br />

‐ Max reservoir volume 4300 ml<br />

‐ Min reservoir volume 300 ml<br />

‐ integral pressure valve +5.3/‐175<br />

mmHg<br />

‐ 1 screen(40μm) & 2 depths filters<br />

‐ Connections: venous return ½”,<br />

venous reservoir outlet‐oxyg. oxyg. Inlet‐<br />

arterial outlet 3/8”.


Equipments (continue)<br />

Membrane oxygenator:<br />

‐ Max BQ rate 8LPM<br />

‐ polypropylene, non porous material<br />

‐ surface area 2.0 m 2<br />

‐ H/E surface area 0.14 m 2<br />

Arterial filter<br />

‐ polyester screen filter 40 μm<br />

‐ effective surface area 400 cm<br />

2<br />

Priming volume (oxygenator, H/E, AF)<br />

500 ml


Equipments (continue)<br />

• Capdioplegia: QMPS2, Quest Medical<br />

• Centrifugal Pump: Maquet Rotaflow<br />

• Console: Maquet tJ Jostra HL20


Additional Equipments<br />

• Cell Saver: Brat‐2<br />

• Gas Filter:Gish<br />

Biomedical 0.2µm<br />

• Heater Cooler: Maquet<br />

Jostra HCU30<br />

• Transfusion Filter: Pll<br />

Pall<br />

SQ40S 40µm<br />

• Venous SAT/HCT<br />

Monitor(influent<br />

spectophotometry)


Patient’s Information<br />

PMH<br />

‐ NIDCM<br />

‐ DM Dx 11/07<br />

‐ H/O LV thrombus (on coumadin)<br />

PSH<br />

‐ PPM/AICD 12/07<br />

‐ LVAD (Heartmate I) 2/1/09<br />

HOME/IN PT MEDS:<br />

‐ ASA 81mg<br />

‐ Enalapril 15mg<br />

‐ Carvedilol 25mg<br />

‐ Milrinone


Thoratec Heartmate LVAD


Patient’s Information<br />

PPM/AICD<br />

LVAD outflow<br />

LVAD inflow


Patient’s Information


• Allergies<br />

NKDA<br />

…Patient’s Information<br />

• Pre‐op labs<br />

Na 139meq/L, K 4.5 meq, Glu 97mg/dL, Pl<br />

184.000, Hgb/Hct 16/44 %,<br />

PT/PTT/INR 14.1/31.3/1.05


Donors Information<br />

• 24 Y/o male, died on car accident<br />

(Buffalo)<br />

• Harvest team assembled and sent for<br />

organs.<br />

• Recipient consented for harvest with<br />

TransMedics module.


Prime/Meds<br />

<br />

1L RL, 1 L Hextend<br />

12.5 gr Mannitol, 50mEq NaHCO 3 , 4,000 units<br />

heparin<br />

Clear Prime Replacement 400ml<br />

(Immediate initiation of CPB )


Calculations<br />

• BSA 2.0m 2 (Wt 80kg, Ht 180cm)<br />

• BQ ‐ 48LPM 4.8 @ 24CI<br />

2.4 ‐ 4.4 LPM @ 2.2 CI<br />

‐ 4.0 LPM @<br />

2.0 CI<br />

• CDHct 31% (pre pump Hct 40%)<br />

• Initial Heparin 24,000 units (300mg/kg)


Pre CPB…<br />

‣ 300pm 3:00 pm. Pt came walking in the OR, & connected with<br />

the Heartmate I console.


Pre CPB…<br />

‣ Arterial line was placed & pt was anesthetized<br />

& intubated (8.0 tube, 24 cm endotracheal<br />

tube)<br />

‣ Sedation was achieved with administration of:<br />

‐ Propofol, 14mg/ml<br />

‐ Fentanyl, 100mcg/ml<br />

‐ Rocuronium, 1mg/ml ‐ Isoflurane 0.5%<br />

‣ Swan ganz catheter was placed<br />

‣ Baseline ACT 144 sec, Pre‐pump Hct 38%.


Pre CPB…<br />

‣ Pre‐op TEE:<br />

EF 25‐35 %, RWMA present, LVAD inflow at<br />

apex/LVAD outflow at asc. aorta, hypokinetic<br />

septum/anterior wall, mildly decreased RV<br />

function, dilated RV, Trace AI,MR,TR,PR


Pre CPB……<br />

‣ Median sternotomy was performed.<br />

LVAD<br />

Pt’s head


Pre CPB……


Going ON CPB…<br />

‣ 24,000 units Heparin was given/Act 573sec.Aorta was<br />

cannulated (7.0mm/21 fr, SF)<br />

‣ 100‐150cc 150cc test dose (line pressure /LPM<br />

appropriate).<strong>Perfusion</strong> team ready for CPB initiation.<br />

‣ SVC cannulated (24 Rt)<br />

‣ Clear prime was taken,400ml. (Usually 1000‐1200 1200 cc)<br />

‣ 17:24 Immediate initiation of CPB ( SVC cannula). Pt was<br />

disconnected d from Heartmate t I. Forane ON.<br />

‣ <strong>Perfusion</strong> initiation check list <strong>com</strong>pleted.<br />

‣ Pt cooled to 32 0 C, IVC cannula in (28 rt).<br />

‣ 17:56 Xcl ON<br />

‣ 18:08 OFF CPB ( IVC cannula came out)<br />

‣ 18:09 ON CPB (IVC cannula re‐placed)


On CPB…<br />

‣ Harvest team in OR. Heart on Transmedics OCS. Video #2/#3<br />

‣ IVC/SVC snared. No change in drainage/Pt’s head checked.<br />

‣ LVAD/Heart were explanted


video 2<br />

Transmedics OCS


Video 2<br />

Transmedics OCS


Explanted heart/LV apex<br />

LV outflow/HM I inflow


Explanted LVAD<br />

(Thoratec heartmate I)<br />

Apex → LVAD inflow<br />

Asc. Aorta ← LVAD outflow<br />

to HM console


Pts heart explanted/IVC/SVC snared<br />

IVC<br />

Aortic Xclamp<br />

SVC


ON CPB…<br />

<br />

ATH cardioplegia/adenosine i d i (maitenance solution) were given to the<br />

donor’s heart through Transmedics devise & the heart was disconnected from<br />

Transmedics Organ Care System. Video #4


ON CPB…<br />

ATH cardioplegia/adenosine (maitenance solution) were given to the<br />

donor’s heart through Transmedics devise & the heart was disconnected from<br />

Transmedics Organ Care System. Video #4<br />

<br />

LA anastomosis was performed<br />

PA/Ao anastomoses were performed<br />

18:38 Pt rewarmed to 37 0 C<br />

18:51 Lidocaine 200mg, Ao XCL OFF (55 min), Ischemic time 68min<br />

IVC/SVC anastomoses were performed.


PA Anastomosis<br />

Ao root vent<br />

Asc. Aorta<br />

PA anastomosis<br />

Aortic Xclamp


IVC Anastomosis<br />

LV vent


Weaning from CPB…<br />

‣ Difficulty weaning OFF CPB. Pt on Milrinone 0.5<br />

mcg/kg/min then Dobutamine 5 mcg/kg/min. RV &<br />

inferior LV hypokinetic.<br />

‣ Pt rested ON CPB x 30min. LV contractility improved, but<br />

RV was still hypokinetic. During arresting time iNO @<br />

20PPM started, & IABP was placed 1:2<br />

‣ Pt weaning successfully OFF CPB.<br />

‣ Chest packed & left open.


Post CPB…<br />

‣ Post‐op op TEE:<br />

EF 35‐44%, RWMA present, inferior & apical hypokinesis, normal RV<br />

size & function, Trace MR, TR, PR, IABP present. (pt on Dobutamine<br />

5 mcg/kg/min, and Milrinone 0.5 mcg/kg/min, iNO 20 PPM).<br />

‣ Post pump ABGs:<br />

‣ pH 7.39, pCO2 38, pO 2 590, Na 139, K 3.8, Glu 93, Hgb/Hct<br />

7/20, Ca 1.22,<br />

‣ Post pump ACT 114sec (baseline 144sec)


Drugs ON CPB…<br />

‣ 80 mcg/cc of Neosynephrine, If MAP < 60 mmHg<br />

‣ Milrinone 2mg<br />

‣ Fentanyl (350mcg)<br />

‣ Vecuronium (10 mg)<br />

‣ Versed (13 mg)<br />

‣ Heparin (16,000Units)<br />

‣ Insulin ( 4 units)<br />

‣ Lidocaine (200 mg)


Final Measurements/Comments<br />

<br />

<br />

<br />

<br />

<br />

CPB Time: 3hr 48min,<br />

XCL Time: 55min,<br />

Ischemic c Time: 1hr 8min (28+40min)<br />

Total Heparin/Protamine 44,000 units/250mg (Hepcon<br />

analysis)<br />

Fluid Balance +1140 cc


Final Measurements/Comments<br />

Pump urine 100ml<br />

FFP 6units<br />

Cell saver 1000ml (4 units)<br />

Platelets 12 units<br />

RBC’s 5 Units<br />

Cryoprecipitate 10 Units


CTICU<br />

‣ Pt arrived @<br />

CTICU intubated & on ventilator support.<br />

Sedated on Propofol 40mcg/kg/min, & on Levophen<br />

3mcg/kg/min, Dobutamine 5mcg/kg/min, Milrinone 0.5<br />

mcg/kg/min, iNO 20PPM, IABP 1:2.<br />

‣ Physical exam: HR 112 ABP 74/46, PAP 16/8, CVP 5,<br />

‣ Vent: Vt 600ml, PEEP 5, FiO2 100%.


POD # 1<br />

Pt returned to OR & chest was closed. iNO & IAPB<br />

were maintained.<br />

POD # 2<br />

Pt was extubated & dissconnected from IABP/iNO<br />

in CTICU.


Concluding…OCS<br />

‣ Maintains organ at a near physiologic functioning state<br />

‣ Increasing organs availability by Increasing the amount of time that an<br />

organ can be maintained outside the body in a condition suitable for<br />

transplantation by reducing time dependent ischemic injury<br />

‣ Tremendous reduction of cold ischemic time.(in our case 1hr 8 min)<br />

‣ Better post operation out<strong>com</strong>es (theoretically)<br />

‣ Easily transportable<br />

‣ Provide surgeons the opportunity to assess the function of the organ<br />

outside the body (loading mode)<br />

‣ Enable resuscitation of the organ and potentially improve function after<br />

removal from donor


•Quand on ne sait pas, on a<br />

peur<br />

•When you don’t know, you<br />

are afraid<br />

Eric cCantona<br />

a<br />

•In my opinion…<br />

PERFUSION=KNOWLEDGE<br />

M. Varsami


Smile more often !!!!!


THANK YOU…

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!